| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Luteolin | Diabetes | 7 | PM | 38425118 | 📋 | Diabetes and its Complications: Role of Luteolin, A Wonder Chemical from the Natural Source |
| Luteolin | Diabetes | 6 | PM | 37513887 | 📋 | Luteolin Protects Pancreatic β Cells against Apoptosis through Regulation of Autophagy and ROS Clearance |
| Luteolin | Diabetes | 4 | PM | 36976050 | 📋 | Evaluation of Antidiabetic Effect of Luteolin in STZ Induced Diabetic Rats: Molecular Docking, Molecular Dynamics, In Vitro and In Vivo Studies |
| Luteolin | Diabetes | 3 | PM | 34734615 | 📋 | The mechanism of delaying starch digestion by luteolin |
| Luteolin | Diabetes | 1 | PM | 30759846 | 📋 | Korean Thistle ( Cirsium japonicum var. maackii (Maxim.) Matsum.): A Potential Dietary Supplement against Diabetes and Alzheimer's Disease |
| Luteolin | Diabetes | 2 | PM | 30462152 | 📋 | Can luteolin be a therapeutic molecule for both colon cancer and diabetes? |
| Luteolin | Diabetes | 5 | PM | 28989580 | 📋 | Luteolin and fisetin suppress oxidative stress by modulating sirtuins and forkhead box O3a expression under in vitro diabetic conditions |
| Luteolin | Diabetes Type 1 | 1 | PM | 31009852 | 📋 | Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses |
| Luteolin | Diabetes Type 2 | 3 | PM | 37749346 | 📋 | Modulation of PPAR-γ, SREBP-1c and inflammatory mediators by luteolin ameliorates β-cell dysfunction and renal damage in a rat model of type-2 diabetes mellitus |
| Luteolin | Diabetes Type 2 | 2 | PM | 35215317 | 📋 | Magnolol and Luteolin Inhibition of α-Glucosidase Activity: Kinetics and Type of Interaction Detected by In Vitro and In Silico Studies |
| Luteolin | Diabetes Type 2 | 1 | PM | 34948468 | 📋 | Luteolin Improves Perivascular Adipose Tissue Profile and Vascular Dysfunction in Goto-Kakizaki Rats |
| Luteolin | Diabetic Cardiomyopathy | 5 | PM | 36852907 | 📋 | The protection of luteolin against diabetic cardiomyopathy in rats is related to reversing JNK-suppressed autophagy |
| Luteolin | Diabetic Cardiomyopathy | 4 | PM | 36423586 | 📋 | Luteolin Attenuates Diabetic Myocardial Hypertrophy by Inhibiting Proteasome Activity |
| Luteolin | Diabetic Cardiomyopathy | 3 | PM | 33900303 | 📋 | Sestrin2 is involved in the Nrf2-regulated antioxidative signaling pathway in luteolin-induced prevention of the diabetic rat heart from ischemia/reperfusion injury |
| Luteolin | Diabetic Cardiomyopathy | 1 | PM | 31009852 | 📋 | Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses |
| Luteolin | Diabetic Cardiomyopathy | 2 | PM | 19892019 | 📋 | Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress |
| Luteolin | Diabetic Complications | 3 | PM | 37103741 | 📋 | Luteolin Mitigates Diabetic Dyslipidemia in Rats by Modulating ACAT-2, PPARα, SREBP-2 Proteins, and Oxidative Stress |
| Luteolin | Diabetic Complications | 1 | PM | 28650731 | 📋 | Combination Treatments with Luteolin and Fisetin Enhance Anti-Inflammatory Effects in High Glucose-Treated THP-1 Cells Through Histone Acetyltransferase/Histone Deacetylase Regulation |
| Luteolin | Diabetic Complications | 4 | PM | 23296950 | 📋 | Chrysin and luteolin attenuate diabetes-induced impairment in endothelial-dependent relaxation: effect on lipid profile, AGEs and NO generation |
| Luteolin | Diabetic Encephalopathy | 1 | PM | 30088237 | 📋 | Luteolin Ameliorates Cognitive Impairments by Suppressing the Expression of Inflammatory Cytokines and Enhancing Synapse-Associated Proteins GAP-43 and SYN Levels in Streptozotocin-Induced Diabetic Rats |
| Luteolin | Diabetic Encephalopathy | 3 | PM | 28801605 | 📋 | Luteolin, a natural flavonoid, inhibits methylglyoxal induced apoptosis via the mTOR/4E-BP1 signaling pathway |
| Luteolin | Diabetic Encephalopathy | 4 | PM | 25206401 | 📋 | Luteolin attenuates neuronal apoptosis in the hippocampi of diabetic encephalopathy rats |
| Luteolin | Diabetic Encephalopathy | 2 | PM | 23415807 | 📋 | Luteolin attenuates diabetes-associated cognitive decline in rats |
| Luteolin | Diabetic Nephropathy | 2 | PM | 32242458 | 📋 | Protective effects of luteolin on nephrotoxicity induced by long-term hyperglycaemia in rats |
| Luteolin | Diabetic Nephropathy | 1 | PM | 31896157 | 📋 | Luteolin Attenuates Diabetic Nephropathy through Suppressing Inflammatory Response and Oxidative Stress by Inhibiting STAT3 Pathway |
| Luteolin | Diabetic Nephropathy | 3 | PM | 30935950 | 📋 | Luteolin attenuates high glucose-induced podocyte injury via suppressing NLRP3 inflammasome pathway |
| Luteolin | Diabetic Retinopathy | 2 | PM | 38633216 | 📋 | SIRT1/P53 in retinal pigment epithelial cells in diabetic retinopathy: a gene co-expression analysis and He-Ying-Qing-Re formula treatment |
| Luteolin | Diabetic Retinopathy | 1 | PM | 34143751 | 📋 | Luteolin, an aryl hydrocarbon receptor antagonist, alleviates diabetic retinopathy by regulating the NLRP/NOX4 signalling pathway: Experimental and molecular docking study |
| Luteolin | Diabetic Ulcers and Sores | 1 | PM | 34209369 | 📋 | Therapeutic Potential of Luteolin on Impaired Wound Healing in Streptozotocin-Induced Rats |
| Luteolin | Diabetic Ulcers and Sores | 2 | PM | 23608325 | 📋 | Wound healing effect of flavonoid rich fraction and luteolin isolated from Martynia annua Linn. on streptozotocin induced diabetic rats |
| Luteolin | Diabetic Vasculopathy | 1 | PM | 34948468 | 📋 | Luteolin Improves Perivascular Adipose Tissue Profile and Vascular Dysfunction in Goto-Kakizaki Rats |
| Luteolin | Hyperglycemia | 2 | PM | 35322626 | 📋 | Meta-analysis Flavonoids from traditional Chinese herbs for diabetes in rats: a network Meta-analysi |
| Luteolin | Hyperglycemia | 1 | PM | 28650731 | 📋 | Combination Treatments with Luteolin and Fisetin Enhance Anti-Inflammatory Effects in High Glucose-Treated THP-1 Cells Through Histone Acetyltransferase/Histone Deacetylase Regulation |
